PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.
From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.
PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.
Antimicrobial resistance has been declared by WHO as one of the top ten threats to global health
There are around 200,000 people in Europe living with moderate to severe stages of HS
RSV infections in older adults account for up to 160,000 hospitalisations each year in the US
The neurological disease affects approximately 2.8 million people worldwide
By Oli Hudson
By Su Smith
By Harry Yeates
By Alix Critchley
By Alice Waterhouse
Pharmaceutical Market Europe - May 2023
Achieving better patient pathways with a focus on the patient; Why TB remains a major global public health challenge; The impact of rare diseases
Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app
Christmas joins from Vynamic, where she founded the firm’s DE&I efforts in 2016
Why patient engagement is essential throughout the entire product life cycle
Dogs Without Borders is a unique project that trains abandoned dogs to become medical detection dogs that can diagnose people living in remote communities
No results were found
Hello. We are the Total Health creative agency. It’s our collective mix of talent that gets us to truly different...